First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review

Cancer Biotherapy and Radiopharmaceuticals, Ahead of Print.

Source: Cancer Biotherapy and Radiopharmaceuticals - January 9, 2023 Category: Cancer & Oncology Authors: Marko Magdi Abdou Sidrak Maria Silvia De Feo Viviana Frantellizzi Andrea Marongiu Salvatore Caponnetto Luca Filippi Susanna Nuvoli Angela Spanu Orazio Schillaci Giuseppe De Vincentis Source Type: research